Cardiovascular disease and hormone replacement therapy: International Menopause Society Expert Workshop

Climacteric

Volumn 3, Issue 4, 2000, Pages 233-240

  Genazzani, A R ^a   Gambacciani, M ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ESTROGEN; GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RALOXIFENE; TIBOLONE; TRIACYLGLYCEROL;

BLOOD PRESSURE; BODY WEIGHT; CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; DEEP VEIN THROMBOSIS; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; MENOPAUSE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; STROKE; CONSENSUS DEVELOPMENT; FEMALE; POSTMENOPAUSE; PRACTICE GUIDELINE;

CORONARY ARTERIOSCLEROSIS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; POSTMENOPAUSE; RALOXIFENE;

EID: 0034470048     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/13697130008500127     Document Type: Conference Paper

References (59)

1. Guidelines for using serum cholesterol, HDL-cholesterol, and trigly-ceride levels as screening tests for preventing coronary heart disease in adults
2. Homeostasis and plasma lipids in postmenopausal women with non-insulin-dependent diabetis mellitus
3. Coronary artery disease in women, ramdomized clinical trials, HERS and RUTH
4. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM
5. Type A behavior pattern, heart disease risk factors, and estrogen replacement in postmenopausal women: The Rancho Bernardo Study
6. The epidemiology of cardiovascular disease in postmenopausal women
7. Effects of low doses of transdermal 17-beta estradiol on carbohydrate metabolism in postmenopausal women
8. Menopause and the risk of coronary heart disease in women
9. Cardiovascular protection by oestrogen - A calcium antagonist effect?
10. The epidemiology of cardiovascular disease in postmenopausal women
11. The effect of menopause on blood lipid and lipo-protein levels
12. Longitudinal study of risk factors for coronary heart disease across the menopausal transition
13. Hormone replacement therapy alters insulin sensitivity in young women with premature ovarian failure
14. Effect of postmenopausal hormone therapy on glucose and insulin concentrations
15. Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes
16. Body weight, body fat distribution and hormonal replacement therapy in early postmenopausal women
17. Treatment of acute myocardial infarction and 30-day mortality among women and men
18. Estrogen for women at varying risk of coronary disease
19. Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women
20. Postmenopausal use of estrogen and conclusion of coronary arteries
21. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease: The Stanford Coronary Risk Intervention Project (SCRIP)
22. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis
23. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
24. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women
25. Age at natural menopause and risk of cardiovascular disease
26. Postmenopausal estrogens and risk of myocardial infarction in diabetic women
27. Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham population
28. The influence of sex hormones on obesity across the female life span
29. Sex steroid influence on hepatic gluconeogenesis and glycogen formation
30. Mechanism of disease: The protective effects of estrogen on the cardiovascular system
31. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
32. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial
33. Blood flow in the internal carotid and middle cerebral arteries: Effects of continuous oral conjugated equine estrogens administration with monthly progestogen supplementation on postmenopausal women
34. The effects of sublingual estradiol on left ventricular function at rest and exercise in postmenopausal women: An echocardiographic assessment
35. Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women
36. Anthropomorphic and psychosocial determinants of visceral obesity in healthy postmenopausal women
37. Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment
38. Early menopause and the risk of myocardial infarction
39. Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism and vascular factors in type 2 diabetes: A prospective study
40. The effect of estrogen on blood pressure in hypertensive postmenopausal women
41. Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet
42. Risk factors for cardiovascular disease in women: Assessment and management
43. Regular physical exercise and low-fat diet: Effects on progression of coronary artery disease
44. Selective estrogen receptor modulators: Different actions on vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells
45. Raloxifene acutely stimulates nitric oxide release from human endothelial cells via an activation of endothelial nitric oxide synthase
46. Tibolone inhibits leukocyte adhesion molecule expression in human endothelial cells
47. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
48. Menopause and heart disease. A review
49. Primary prevention of coronary heart disease in women through diet and lifestyle
50. Postmenopausal estrogen use and coronary atherosclerosis
51. Hormone replacement therapy reduces mean 24-hour blood pressure and its variability in postmenopausal women with treated hypertension
52. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The PEPI Trial
53. The North American Menopause Society 1998 menopause survey. I. Postmenopausal women's perceptions about menopause and midlife
54. Sex-based differences in early mortality after myocardial infarction
55. Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women
56. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
57. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: A randomized, controlled trial
58. Oestrogen improves exercise-induced myocardial ischaemia in women
59. 17beta-estradiol decreases endothelin-1 levels in the coronary circulation of postmenopausal women with coronary artery disease